From Egg Harbor Township, New Jersey, USA:
I understand there is a new 24 hour long acting insulin which has just been approved for marketing by the FDA. It is Lantus Glargine, made by Hoechst. Will this be a better option than NPH or Ultralente for a 4 year old recently diagnosed Type 1 child? What are your thoughts on the new insulin, and when will it be available by prescription?
Glargine is a new insulin analog that offers a very even release over the 24 hours after injection. Basically it is equivalent to two injections of NPH over the same period; but otherwise affords no striking improvement in control. It is likely to find a place in intensive insulin therapy where it is used with a Humalog dose after meals that is adjusted for the premeal blood sugar and appetite.
Original posting 17 Jul 2000
Posted to Insulin
Last Updated: Tuesday April 06, 2010 15:09:12
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.